Search results
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $143.00
ETF DAILY NEWS· 5 hours agoMerck & Co., Inc. (NYSE:MRK – Free Report) had its target price boosted by Truist Financial from $142.00 to $143.00 in a research report ...
Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 2 days agoMerck & Co., Inc. (NYSE:MRK) just released its quarterly report and things are looking bullish. The...
Here’s Why Merck & Co. (MRK) Outperformed in Q1
Insider Monkey via Yahoo Finance· 6 days agoBaron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be...
What Direction Does Merck & Co Inc (NYSE: MRK) Analysts Think The Company Will Take? – Stocks...
Stocks Register· 5 days agoThe trading price of Merck & Co Inc (NYSE:MRK) remained unchanged on Tuesday, April 23, closing at $126.88. The company’s P/E ratio in ...
Merck jumps on profit beat as Bristol Myers Squibb slips to a loss
Proactive Investors· 4 days agoMerck & Co Inc (NYSE:MRK, ETR:6MK), the pharmaceutical firm, saw its shares tick 3.5% higher after...
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in...
Bennington Banner· 5 days agoUpon the execution of the agreement, Hanmi Pharmaceutical will conduct a phase 1 clinical trial to...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 4 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
MRK Stock Sees Surge of Approximately 1.30% in Last Five Days – Knox Daily
Knox Daily· 4 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Merck & Co Inc shares ...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 4 days agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Reuters· 4 days ago, opens new tab on Thursday raised its annual profit and revenue forecast on the back of strong...